Amplitude (NASDAQ:AMPL – Get Rating) was downgraded by equities researchers at UBS Group from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, The Fly reports.

Hologic (NASDAQ:HOLX – Get Rating) had its target price increased by equities researchers at Wells Fargo & Company from $75.00 to $80.00 in a research note issued on Tuesday, The Fly reports. Wells Fargo & Company’s price objective would indicate a potential upside of 0.26% from the stock’s current price.

Hydro One (TSE:H – Get Rating) had its target price lifted by investment analysts at CIBC from C$36.00 to C$39.00 in a report issued on Tuesday, BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. CIBC’s target price would suggest a potential upside of 7.88% from the company’s previous close.

Aon plc (NYSE:AON – Get Rating) announced a quarterly dividend on Tuesday, January 10th, RTT News reports. Shareholders of record on Wednesday, February 1st will be given a dividend of 0.56 per share by the financial services provider on Wednesday, February 15th. This represents a $2.24 dividend on an annualized basis and a yield of 0.73%.

Cintas Co. (NASDAQ:CTAS – Get Rating) announced a quarterly dividend on Tuesday, January 10th, RTT News reports. Stockholders of record on Wednesday, February 15th will be paid a dividend of 1.15 per share by the business services provider on Wednesday, March 15th. This represents a $4.60 annualized dividend and a dividend yield of 1.03%.

Enovix (NASDAQ:ENVX – Get Rating) had its target price decreased by equities research analysts at B. Riley from $19.00 to $18.00 in a report issued on Wednesday, The Fly reports. B. Riley’s price target points to a potential upside of 48.51% from the stock’s current price.

GlycoMimetics, Inc. (NASDAQ:GLYC – Get Rating) major shareholder Scott D. Sandell sold 174,814 shares of the company’s stock in a transaction on Tuesday, January 3rd. The shares were sold at an average price of $2.99, for a total value of $522,693.86. Following the completion of the transaction, the insider now directly owns 3,960,002 shares in the company, valued at approximately $11,840,405.98. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

SMART Global Holdings, Inc. (NASDAQ:SGH – Get Rating) shares gapped up before the market opened on Wednesday following a stronger than expected earnings report. The stock had previously closed at $15.12, but opened at $16.37. SMART Global shares last traded at $16.15, with a volume of 7,330 shares changing hands.

CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) was down 3.6% during trading on Wednesday following insider selling activity. The company traded as low as $5.65 and last traded at $5.65. Approximately 87,103 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 2,188,158 shares. The stock had previously closed at $5.86.Specifically, Director Michael A. Metzger sold 91,500 shares of CTI BioPharma stock in a transaction that occurred on Tuesday, November 8th. The stock was sold at an average price of $5.58, for a total transaction of $510,570.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, CEO Adam R. Craig sold 84,683 shares of CTI BioPharma stock in a transaction that occurred on Tuesday, January 3rd. The stock was sold at an average price of $6.01, for a total transaction of $508,944.83. Following the completion of the sale, the chief executive officer now directly owns 29,440 shares of the company’s stock, valued at approximately $176,934.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Michael A. Metzger sold 91,500 shares of CTI BioPharma stock in a transaction that occurred on Tuesday, November 8th. The stock was sold at an average price of $5.58, for a total value of $510,570.00. The disclosure for this sale can be found here. In the last three months, insiders sold 203,204 shares of company stock worth $1,181,911. 10.20% of the stock is owned by company insiders.

Camping World Holdings, Inc. (NYSE:CWH – Get Rating) saw a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 9,000,000 shares, an increase of 7.8% from the November 30th total of 8,350,000 shares. Approximately 23.6% of the company’s shares are short sold. Based on an average trading volume of 969,900 shares, the days-to-cover ratio is currently 9.3 days.